FDA Inspection 1027866 — Marco Antonio Alvarez Gonzalez, MD, PhD
The FDA completed an inspection of Marco Antonio Alvarez Gonzalez, MD, PhD on Sep 15, 2017 in Barcelona. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 15, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Barcelona (Spain)
Additional details
Clinical Investigator (CI)